BioSpecifics Technologies Corporation Reports Second Quarter 2013 Financial Results

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LYNBROOK, N.Y., Aug. 8, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (BSTC), a biopharmaceutical company developing first-in-class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, today reported its financial results for the second quarter ended June 30, 2013 and provided a corporate update.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news